AT&T and Verizon were penalized millions of dollars for what the agency said was a failure to protect consumer information. The companies say they were deprived of their right to a jury trial.
Category: Regulation and Deregulation of Industry
-
Second Jury Finds Uber Responsible for Sexual Assault by a Driver
The ride-hailing giant has now lost the first two of more than 3,000 pending federal lawsuits.
-
Federal Court Temporarily Freezes Nexstar’s Merger With Tegna
The judge said the two television companies could not combine operations while an antitrust lawsuit proceeded. Nexstar said its deal was already done.
-
New Rules Hinder Foreign Firms From Moving Supply Chains From China
Multinationals in China are concerned that the regulations could allow authorities to penalize companies and executives for shifting supply chains away from the country.
-
White House and Crypto Industry Fight Bank Lobby Over Stablecoin Income
The Trump administration backed a proposal for stablecoin issuers to offer yield to investors.
-
Fed Minutes Show Officials in No Rush to Cut as Iran War Scrambled Outlook
The conflict in the Middle East has left the Federal Reserve braced for higher inflation, upending expectations about if officials will restart interest rate cuts.
-
Jamie Dimon Cites Risks From War, Private Credit, Inflation and More
In his annual letter to shareholders, Jamie Dimon, the chief executive of JPMorgan Chase, said investors and businesses faced a series of challenges.
-
‘Under Protest,’ Raw Dairy Farm Recalls Cheddar Linked to 9 E. Coli Cases
Raw Farm, a dairy producer in California, denies that its products have caused the outbreak, which has sickened people in three states.
-
Republicans Seek Protections for Oil Giants Against Climate Lawsuits
Utah passed a law to insulate oil companies against efforts to make them pay for their role in global warming. A nationwide version is in the works.
-
Eli Lilly Will Buy a Narcolepsy Drug Developer for $6.3 Billion
Eli Lilly plans to acquire Centessa Pharmaceuticals, which has been conducting a midstage clinical trial of its lead drug.